Detection of Gram-negative β-lactamase producing pathogens in the Clinical Lab

Current Pharmaceutical Design

Volumn 19, Issue 2, 2013, Pages 250-256

  Thomson, Kenneth S ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AmpC; Carbapenemase; CTX M; ESBL; KPC; Metallo lactamase; lactamase

Indexed keywords

AZTREONAM; BETA LACTAMASE AMPC; CARBAPENEMASE; CEFEPIME; CEFOTAXIME; CEFPODOXIME; CEFTAZIDIME; CEPHALOSPORIN; EXTENDED SPECTRUM BETA LACTAMASE; PENICILLIN DERIVATIVE;

ACINETOBACTER BAUMANNII; AEROMONAS; BROTH DILUTION; CITROBACTER FREUNDII; DRUG HYDROLYSIS; ENTEROBACTERIACEAE; ENZYME SYNTHESIS; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; HAFNIA ALVEI; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; MORGANELLA MORGANII; NONHUMAN; PRIORITY JOURNAL; PROTEUS MIRABILIS; PROVIDENCIA; PSEUDOMONAS AERUGINOSA; REVIEW; SERRATIA MARCESCENS;

EID: 84877931088     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161213804070249     Document Type: Review

References (68)

1. Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update Clin Microbiol Rev 2005; 18: 657-86.
2. Bradford PA. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001; 14: 933-51.
3. Paterson DL, Ko WC, Von Gottberg A, et al. International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial Infections Ann Intern Med 2004; 140: 26-32.
4. Kliebe C, Nies BA, Meyer JF, Tolxdorff-Neutzling RM, Wiedemann B. Evolution of plasmid-coded resistance to broad spectrum cephalosporins Antimicrob. Agents Chemother 1985; 28: 302-7.
5. National Committee for Clinical Laboratory Standards; National Committee for Clinical Laboratory Standards: Wayne, PA 2004.
6. Clinical and Laboratory Standards Institute; Clinical and Laboratory Standards Institute: Wayne, PA 2010.
7. Kahlmeter G. Breakpoints for intravenously used cephalosporins in Enterobacteriaceae--EUCAST and CLSI breakpoints Clin Microbiol Infect 2008; 14 Suppl 1: 169-74.
8. Paterson DL, Ko WC, Von Gottberg A, et al. Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical laboratory. J Clinical Microbiology 2001; 39: 2206-12.
9. Bhavnani SM, Ambrose PG, Craig WA, Dudley MN, Jones RN. Outcomes evaluation of patients with ESBL-and non-ESBLproducing Escherichia coli and Klebsiella species as defined by CLSI reference methods: report from the SENTRY Antimicrobial Surveillance Program Diagn Microbiol Infect Dis 2006; 54: 231-6.
10. Karas JA, Pillay DG, Muckart D, Sturm AW. Treatment failure due to extended spectrum ß-lactamase. J Antimicrobial Chemotherapy 1996; 37 203-204.
11. Thomson KS. Controversies about extended-spectrum and AmpC beta-lactamases. Emerg Infect Dis 2001; 7: 333-6.
12. Jarlier V, Nicolas M.-H, Fournier G, Philippon A. Extended broadspectrum ß-lactamases conferring transferable resistance to newer ß-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infectious Disease 1988; 10: 867-8.
13. Thomson KS, Sanders CC. Detection of extended-spectrum ßlactamases in members of the family Enterobacteriaceae: Comparison of the double-disk and three-dimensional tests. Antimicrobial Agents Chemotherapy 1992; 36: 1877-1882.
14. Pitout JD, Hossain A, Hanson ND. Phenotypic and molecular detection of CTX-M-beta-lactamases produced by Escherichia coli and Klebsiella spp J Clin Microbiol 2004; 42: 5715-21.
15. Moland ES, Hong SG, Thomson KS, Larone DH, Hanson ND. Klebsiella pneumoniae isolate producing at least eight different beta-lactamases, including AmpC and KPC beta-lactamases Antimicrob Agents Chemother 2007; 51: 800-1.
16. Bulik CC, Fauntleroy KA, Jenkins SG, et al. Comparison of Meropenem MICs and Susceptibilities for Carbapenemase-Producing Klebsiella pneumoniae Isolates by Various Testing Methods J Clin Microbiol 2010; 48: 2402-6.
17. Clinical and Laboratory Standards Institute; Clinical and Laboratory Standards Institute: Wayne, PA 2009.
18. Robberts FJ, Kohner PC, Patel R. Unreliable extended-spectrum beta-lactamase detection in the presence of plasmid-mediated AmpC in Escherichia coli clinical isolates J Clin Microbiol 2009; 47: 358-61.
19. Paterson DL, Ko WC, Von Gottberg A, et al. Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases Clin Infect Dis 2004; 39: 31-7.
20. Quinn JP. Clinical strategies for serious infection: a North American perspective Diagn Microbiol Infect Dis 1998; 31: 389-95.
21. Brun-Buisson C, Legrand P, Philippon A, Montravers F, Ansquer M, Duval J. Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae. Lancet 1987; ii: 302-6.
22. Moland ES, Kim SY, Hong SG, Thomson KS. Newer betalactamases: Clinical and Laboratory Implications, Part II Clin Microbiol Newsletter 2008; 30: 79-84.
23. Moland ES, Hanson ND, Black JA, Hossain A, Song W, Thomson KS. Prevalence of newer KK-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002 J Clin Microbiol 2006; 44: 3318-24.
24. Lewis JS., 2nd; Herrera M, Wickes B, Patterson JE, Jorgensen JH. First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system Antimicrob Agents Chemother 2007; 51: 4015-21.
25. Song W, Moland ES, Hanson ND, Lewis JS, Jorgensen JH, Thomson KS. Failure of Cefepime Therapy in Treatment of Klebsiella pneumoniae Bacteremia J Clin Microbiol 2005; 43: 4891-4.
26. Poirel L, Menuteau O, Agoli N, Cattoen C, Nordmann P. Outbreak of extended-spectrum beta-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital J Clin Microbiol 2003; 41: 3542-7.
27. Crowley B, Ratcliffe G. Extended-spectrum beta-lactamases in Enterobacter cloacae: underestimated but clinically significant! J Antimicrob Chemother 2003; 51: 1316-7.
28. Levison ME. Plasmid-mediated Extended-spectrum beta-Lactamases in Organisms Other Than Klebsiella pneumoniae and Escherichia coli: A Hidden Reservoir of Transferable Resistance Genes Curr Infect Dis Rep 2002; 4: 181-3.
29. Neonakis IK, Scoulica EV, Dimitriou SK, Gikas AI, Tselentis YJ. Molecular epidemiology of extended-spectrum beta-lactamases produced by clinical isolates in a university hospital in Greece: detection of SHV-5 in Pseudomonas aeruginosa and prevalence of SHV-12 Microb Drug Resist 2003; 9: 161-5.
30. Tzelepi E, Giakkoupi P, Sofianou D, Loukova V, Kemeroglou A, Tsakris A. Detection of extended-spectrum beta-lactamases in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes J Clin Microbiol 2000; 38: 542-6.
31. Gottlieb T, Wolfson C. Comparison of the MICs of cefepime for extended-spectrum beta-lactamase-producing and non-extendedspectrum beta-lactamase-producing strains of Enterobacter cloacae[letter]. J Antimicrob Chemother 2000; 46: 330-331.
32. Pagani L, Mantengoli E, Migliavacca R, et al. Multifocal detection of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum beta-lactamase in Northern Italy J Clin Microbiol 2004; 42: 2523-9.
33. Sirot J. Detection of extended-spectrum plasmid-mediated betalactamases by disk diffusion Clin Microbiol Infect 1996; 2 Suppl 1: S35-9.
34. Sanders CC, Barry AL, Washington JA, et al. Detection of extended-spectrum-ß-lactamase-producing members of the family Enterobacteriaceae with the Vitek ESBL test. J Clinical Microbiology 1996; 34: 2997-3001.
35. Sanguinetti M, Posteraro B, Spanu T, et al. Characterization of clinical isolates of Enterobacteriaceae from Italy by the BD Phoenix extended-spectrum beta-lactamase detection method J Clin Microbiol 2003; 41: 1463-8.
36. Spanu T, Sanguinetti M, Tumbarello M, et al. Evaluation of the new VITEK 2 extended-spectrum beta-lactamase (ESBL) test for rapid detection of ESBL production in Enterobacteriaceae isolates J Clin Microbiol 2006; 44: 3257-62.
37. Thomson KS, Cornish NE, Hong SG, Hemrick K, Herdt C, Moland ES. Comparison of Phoenix and VITEK 2 extended-spectrum-betalactamase detection tests for analysis of Escherichia coli and Klebsiella isolates with well-characterized beta-lactamases J Clin Microbiol 2007; 45: 2380-4.
38. Jacoby GA. AmpC beta-lactamases Clin Microbiol Rev 2009; 22: 161-82.
39. Munier GK, Johnson CL, Snyder JW, Moland ES, Hanson ND, Thomson KS. Positive extended-spectrum TT-lactamase (ESBL) screening results may be due to AmpC ee-lactamases more often than to ESBLs J Clinical Microbiology 2010; 48: 673-4.
40. Sanders WE, Sanders CC. Inducible ß-lactamases: clinical and epidemiological implications for use of newer cephalosporins. Review of Infectious Diseases 1988; 10: 830-8.
41. Perez-Perez FJ, Hanson ND. Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR J Clin Microbiol 2002; 40: 2153-62.
42. Ruppe E, Bidet P, Verdet C, Arlet G, Bingen E. First detection of the Ambler class C 1 AmpC beta-lactamase in Citrobacter freundii by a new, simple double-disk synergy test J Clin Microbiol 2006; 44: 4204-7.
43. Black JA, Moland ES, Thomson KS. AmpC disk test for detection of plasmid-mediated AmpC beta-lactamases in Enterobacteriaceae lacking chromosomal AmpC beta-lactamases J Clin Microbiol 2005; 43: 3110-3.
44. Gots JS. The detection of penicillinase-producing properties of microorganisms Science 1945; 102: 309.
45. Yong D, Park R, Yum J, Lee K, Choi E, Chong Y. Further modification of the Hodge test to screen AmpC beta-lactamase (CMY-1)-producing strains of Escherichia coli and Klebsiella pneumoniae. J Microbiol Methods 2002; 51: 407.
46. Pai H, Kang CI, Byeon JH, et al. Epidemiology and clinical features of bloodstream infections caused by AmpC-type-betalactamase-producing Klebsiella pneumoniae Antimicrob Agents Chemother 2004; 48: 3720-8.
47. Sanders CC, Sanders WE. Jr. Emergence of resistance to cefamandole: possible role of cefoxitin-inducible beta-lactamases. Antimicrobial Agents Chemotherapy 1979; 15: 792-7.
48. Queenan AM, Bush K. Carbapenemases: the versatile betalactamases Clin Microbiol Rev 2007 20; 440-58.
49. Walsh TR, Toleman MA, Poirel L, Nordmann P. Metallo-betalactamases: the quiet before the storm? Clin Microbiol Rev 2005; 18: 306-25.
50. Falcone M, Mezzatesta ML, Perilli M, et al. Infections with VIM-1 metallo-{beta}-lactamase-producing Enterobacter cloacae and their correlation with clinical outcome J Clin Microbiol 2009; 47: 3514-9.
51. Daikos GL, Vryonis E, Psichogiou M, et al. Risk factors for bloodstream infection with Klebsiella pneumoniae producing VIM-1 metallo-{beta}-lactamase. J Antimicrob Chemother 2010; 65: 784-8.
52. Daikos GL, Petrikkos P, Psichogiou M, et al. Prospective observational study of the impact of VIM-1 metallo-beta-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections Antimicrob Agents Chemother 2009; 53: 1868-73.
53. Weisenberg SA, Morgan DJ, Espinal-Witter R, Larone DH. Clinical outcomes of patients with Klebsiella pneumoniae carbapenemase-producing K. pneumoniae after treatment with imipenem or meropenem Diagn Microbiol Infect Dis 2009; 64: 233-5.
54. Kumarasamy KK, Toleman MA, Walsh TR, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study Lancet Infect Dis 2010; 10: 597-602.
55. Leavitt A, Navon-Venezia S, Chmelnitsky I, Schwaber MJ, Carmeli Y. Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital Antimicrob Agents Chemother 2007; 51: 3026-9.
56. Bratu S, Mooty M, Nichani S, et al. Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection Antimicrob Agents Chemother 2005; 49: 3018-20.
57. Zhang R, Zhou HW, Cai JC, Chen GX. Plasmid-mediated carbapenem-hydrolysing beta-lactamase KPC-2 in carbapenem-resistant Serratia marcescens isolates from Hangzhou China J Antimicrob Chemother 2007; 59: 574-6.
58. Naas T, Nordmann P, Vedel G, Poyart C. Plasmid-Mediated Carbapenem-Hydrolyzing {beta}-Lactamase KPC in a Klebsiella pneumoniae Isolate from France Antimicrob Agents Chemother 2005; 49: 4423-4.
59. Cuzon G, Naas T, Demachy MC, Nordmann P. Plasmid-Mediated Carbapenem-Hydrolyzing {beta}-Lactamase KPC-2 in Klebsiella pneumoniae Isolate from Greece Antimicrob Agents Chemother 2008; 52: 796-7.
60. Migliavacca R, Docquier JD, Mugnaioli C, et al. Simple microdilution test for detection of metallo-beta-lactamase production in Pseudomonas aeruginosa J Clin Microbiol 2002; 40: 4388-90.
61. Arakawa Y, Shibata N, Shibayama K, et al. Convenient test for screening metallo-beta-lactamase-producing gram-negative bacteria by using thiol compounds J Clin Microbiol 2000; 38: 40-3.
62. Kim SY, Hong SG, Moland ES, Thomson KS. Convenient test using a combination of chelating agents for detection of metallo-uu-lactamases in the clinical laboratory J Clin Microbiol 2007; 45: 2798-801.
63. Walsh TR, Bolmstrom A, Qwarnstrom A, Gales A. Evaluation of a new Etest for detecting metallo-beta-lactamases in routine clinical testing J Clin Microbiol 2002; 40: 2755-9.
64. Ratkai C, Quinteira S, Grosso F, Monteiro N, Nagy E, Peixe L. Controlling for false positives: interpreting MBL Etest and MBL combined disc test for the detection of metallo-beta-lactamases J Antimicrob Chemother 2009; 64: 657-8.
65. Anderson KF, Lonsway DR, Rasheed JK, et al. Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae J Clin Microbiol 2007; 45: 2723-5.
66. Tsakris A, Kristo I, Poulou A, Markou F, Ikonomidis A, Pournaras S. First occurrence of KPC-2-possessing Klebsiella pneumoniae in a Greek hospital and recommendation for detection with boronic acid disc tests J Antimicrob Chemother 2008; 62: 1257-60.
67. Doi Y, Potoski BA, Adams-Haduch JM, Sidjabat HE, Pasculle AW, Paterson DL. Simple disk-based method for detection of Klebsiella pneumoniae carbapenemase-type beta-lactamase by use of a boronic acid compound J Clin Microbiol 2008; 46: 4083-6.
68. Tsakris A, Kristo I, Poulou A, et al. Evaluation of boronic acid disk tests for differentiating KPC-possessing Klebsiella pneumoniae isolates in the clinical laboratory J Clin Microbiol 2009; 47: 362-7.